The Compact Dynamic Beamstop developed at Lawrence Berkeley National Laboratory (LBNL) and licensed exclusively by MiTeGen, LLC enhances protein crystallography research that supports development of treatments for diseases such as cancer, AIDS, Ebola, tuberculosis. In protein crystallography research, scientists use intense X-rays to extract structural and biological … [Read more...] about Tiny Tool for Life-Saving Research
SF Business Times Highlights Berkeley Lab Tech Transfer
In a special section saluting innovation in Berkeley, the San Francisco Business Times credits Berkeley Lab's research and technology transfer programs in making startups such as Nanosys and Aeroseal a success. The article highlights recent developments from Berkeley Lab's Innovation and Partnerships Office, such as the Innovation Portal for managing intellectual property and … [Read more...] about SF Business Times Highlights Berkeley Lab Tech Transfer
Intelligent System for Personalized Ambient Comfort and Energy Efficiency 2016-183
APPLICATIONS OF TECHNOLOGY: Commercial buildings including offices, hotels, classrooms with multiple occupants with varying comfort needs Residences Vehicles HVAC and lighting controls Intelligent furniture ADVANTAGES: Provides hyperlocal environmental sensing, e.g., ambient temperature, humidity, air quality, daylight, noise Integrates localized … [Read more...] about Intelligent System for Personalized Ambient Comfort and Energy Efficiency 2016-183
Decorporation Agent for Therapeutic Chelation of Industrial and Clinical Toxic Heavy Metals 2016-078
APPLICATIONS OF TECHNOLOGY: Treatment and prevention of gadolinium deposition in patients undergoing MRIs Treatment for exposure to toxic metals including lead, tin, and cadmium ADVANTAGES: Strong decorporation efficacy High affinity for the toxic elements gadolinium (Gd), lead (Pb), tin (Sn), and cadmium (Cd) ABSTRACT: Researchers at Berkeley Lab have … [Read more...] about Decorporation Agent for Therapeutic Chelation of Industrial and Clinical Toxic Heavy Metals 2016-078
Oral Dosage Forms for Actinide Decorporation Agent 2016-079
APPLICATIONS OF TECHNOLOGY: Treatment of radionuclide exposure Treatment or prevention of gadolinium (Gd) deposition from MRIs Treatment for exposure to toxic metals including lead (Pb), tin (Sn), and cadmium (Cd) ADVANTAGES: Administered orally in a variety of dosage forms Ease of clinical use Enables use during emergencies or mass … [Read more...] about Oral Dosage Forms for Actinide Decorporation Agent 2016-079